Severe Alzheimer's Disease: Treatment Effects on Function and Care Requirements

Diana Kerwin; Thomas H. Claus

doi:10.1016/j.jamda.2010.06.011

Severe Alzheimer's Disease: Treatment Effects on Function and Care Requirements

Diana Kerwin, Thomas H. Claus

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Abstract

The number and age of patients with Alzheimer's disease (AD) continues to increase dramatically with more patients requiring long-term skilled care. The care of patients with AD, particularly those with severe AD, is a challenge that long-term care administrators are facing with increasing frequency. The therapeutic approach to patients in the moderate to severe stages of AD is a combination of pharmacologic agents to maximize patient function and independence and is cost effective for the nursing home facility and the patient. Here we review the use of drug therapy in patients with severe AD, focusing on function and long-term care perspectives.

Original language	English (US)
Pages (from-to)	99-104
Number of pages	6
Journal	Journal of the American Medical Directors Association
Volume	12
Issue number	2
DOIs	https://doi.org/10.1016/j.jamda.2010.06.011
State	Published - Feb 2011

Keywords

Alzheimer's disease
Cholinesterase inhibitors
Function
Memantine

ASJC Scopus subject areas

General Nursing
Health Policy
Geriatrics and Gerontology

Access to Document

10.1016/j.jamda.2010.06.011

Cite this

@article{fd64fa53a02a45fe9738adc8fd3c7ae3,

title = "Severe Alzheimer's Disease: Treatment Effects on Function and Care Requirements",

abstract = "The number and age of patients with Alzheimer's disease (AD) continues to increase dramatically with more patients requiring long-term skilled care. The care of patients with AD, particularly those with severe AD, is a challenge that long-term care administrators are facing with increasing frequency. The therapeutic approach to patients in the moderate to severe stages of AD is a combination of pharmacologic agents to maximize patient function and independence and is cost effective for the nursing home facility and the patient. Here we review the use of drug therapy in patients with severe AD, focusing on function and long-term care perspectives.",

keywords = "Alzheimer's disease, Cholinesterase inhibitors, Function, Memantine",

author = "Diana Kerwin and Claus, {Thomas H.}",

year = "2011",

month = feb,

doi = "10.1016/j.jamda.2010.06.011",

language = "English (US)",

volume = "12",

pages = "99--104",

journal = "Journal of the American Medical Directors Association",

issn = "1525-8610",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Severe Alzheimer's Disease

T2 - Treatment Effects on Function and Care Requirements

AU - Kerwin, Diana

AU - Claus, Thomas H.

PY - 2011/2

Y1 - 2011/2

N2 - The number and age of patients with Alzheimer's disease (AD) continues to increase dramatically with more patients requiring long-term skilled care. The care of patients with AD, particularly those with severe AD, is a challenge that long-term care administrators are facing with increasing frequency. The therapeutic approach to patients in the moderate to severe stages of AD is a combination of pharmacologic agents to maximize patient function and independence and is cost effective for the nursing home facility and the patient. Here we review the use of drug therapy in patients with severe AD, focusing on function and long-term care perspectives.

AB - The number and age of patients with Alzheimer's disease (AD) continues to increase dramatically with more patients requiring long-term skilled care. The care of patients with AD, particularly those with severe AD, is a challenge that long-term care administrators are facing with increasing frequency. The therapeutic approach to patients in the moderate to severe stages of AD is a combination of pharmacologic agents to maximize patient function and independence and is cost effective for the nursing home facility and the patient. Here we review the use of drug therapy in patients with severe AD, focusing on function and long-term care perspectives.

KW - Alzheimer's disease

KW - Cholinesterase inhibitors

KW - Function

KW - Memantine

UR - http://www.scopus.com/inward/record.url?scp=78751704131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751704131&partnerID=8YFLogxK

U2 - 10.1016/j.jamda.2010.06.011

DO - 10.1016/j.jamda.2010.06.011

M3 - Review article

C2 - 21266285

AN - SCOPUS:78751704131

SN - 1525-8610

VL - 12

SP - 99

EP - 104

JO - Journal of the American Medical Directors Association

JF - Journal of the American Medical Directors Association

IS - 2

ER -

Severe Alzheimer's Disease: Treatment Effects on Function and Care Requirements

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this